MMP9 and metastatic malignant neoplasm in the lymph nodes: Previous studies revealed that MMP9 was significantly associated with poor survival and lymph node metastasis in ICC (Shirabe et al., 1999; Sirica et al., 2009) and various inflammation states (Borjini et al., 2019; Jing et al., 2020).